HopeStage
Back to all studies
UnknownNCT01221792

Carvedilol Versus Placebo for Treatment in PTSD (PTSD)

This study evaluates the safety and effectiveness of Carvedilol for people with PTSD.

Medication studyAges 18–70United States
The study in practice

Understand this study

What is this study about?

This study evaluates the safety and effectiveness of Carvedilol for people with PTSD.

Who could participate?

This study is for people with PTSD. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.

Listed locations
San Diego and 2 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateOctober 2010
Recruitment status
Unknown
Enrollment listed in the registry
80
Sponsor
Columbia Northwest Pharmaceuticals
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT01221792
Official title
Show the full official title

A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study to Assess the Safety and Efficacy of Carvedilol Versus Placebo in the Treatment of Post Traumatic Stress Disorder

Recruitment & locations

Status unknown

San Diego · Lake Charles · Bellevue

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What is this study about?

This study evaluates the safety and effectiveness of Carvedilol for people with PTSD.

Who is behind this study?

The study sponsor is Columbia Northwest Pharmaceuticals.

Does this study involve medication?

Yes. The study involves medication, including Carvedilol and Placebo.

Who can participate?

This study is for people with PTSD. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.

Want to explore more studies?

Explore studies